Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Deloitte
Chubb
Federal Trade Commission
Julphar
Baxter
Farmers Insurance
Queensland Health
Accenture

Generated: May 20, 2018

DrugPatentWatch Database Preview

TANDEARIL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Tandearil patents expire, and when can generic versions of Tandearil launch?

Tandearil is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in TANDEARIL is oxyphenbutazone. There is one drug master file entry for this compound. Additional details are available on the oxyphenbutazone profile page.
Summary for TANDEARIL
Drug patent expirations by year for TANDEARIL
Medical Subject Heading (MeSH) Categories for TANDEARIL
Synonyms for TANDEARIL
1-(p-Hydroxyphenyl)-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine
1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione
1-(p-hydroxyphenyl)-2-phenyl-4-butylpyrazolidine-3,5-dione
1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine
1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine
1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butylpyrazolidine
129-20-4
3, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
3, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-
3,5-Dioxo-1-phenyl-2-(p-hydroxyphenyl)-4-N-butylpyrazolidene
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl- (9CI)
3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-
3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl- (VAN)
3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl- (VAN) (8CI)
3,5-Pyrazolidinedione,4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
4-butyl-1-(4-hydroxyphenyl)-2-phenyl-1,2-diazolidine-3,5-dione
4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione
4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione
4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione
4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine
4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione
AB00052064
AB00052064_08
AC1L1IMG
AC1Q6L3L
AI3-26792
AKOS024362800
AN-23036
API0006917
Aradinum
Artroflog
BDBM200298
BM 1
BPBio1_001076
BRD-A33749298-001-05-0
BRN 0307474
BSPBio_000978
BSPBio_002149
Butaflogin
Butanora
Butanova
Butapirone
Butazonic
Butilene
C-44320
C19494
Californit
CAS-129-20-4
CCG-38944
CCRIS 6717
CHEBI:76258
CHEMBL1228
Cinophen-N
Crovaril
CTK8G2232
D06ZPS
D08324
DB03585
Deflogin
DivK1c_000302
DSSTox_CID_25291
DSSTox_GSID_45291
DSSTox_RID_80784
DTXSID1045291
EINECS 204-936-2
Etrozolidina
Flamaril
Flanaril
Flegmostam
Flogal
Floghene
Flogistin
Flogitolo
Flogodin
Flogoril
Flogostop
Flopirina
Frabel
FT-0673468
G 27202
Genal
HE062036
HE300379
HE305446
HFHZKZSRXITVMK-UHFFFAOYSA-N
HMS1571A20
HMS1920D20
HMS2091L20
HMS2098A20
HMS2236G07
HMS3373B01
HMS500P04
HSDB 3144
Hydroxyphenylbutazon
Hydroxyphenylbutazone
IDI1_000302
Idrobutazina
Infamil
Infammil
Ipabutona
Iridil
Isobutazina
Isobutil
J-005659
KBio1_000302
KBio2_001553
KBio2_004121
KBio2_006689
KBio3_001649
KBioGR_001729
KBioSS_001553
labotest-bb lt00134684
LS-128612
MCULE-3785704527
metabolite
Metabolite I
metabolitie
MLS003373849
MolPort-003-666-251
Mysite
NCGC00016389-01
NCGC00094748-01
NCGC00094748-02
NCGC00094748-03
NCGC00094748-04
NCGC00094748-07
Neo-Farmadol
Neofen
NINDS_000302
NSC 526053
NSC-526053
NSC-757261
NSC526053
NSC757261
Offitril
OPB
Optimal
Ossifenbutazone
Ossifenbutazone [DCIT]
Oxalid
Oxazolidin
Oxazolidin-Geigy
Oxazolioin
Oxi-Fenibutol
Oxibutol
Oxifenbutazona
Oxifenbutazona [INN-Spanish]
Oxifenylbutazon
Oxiphenbutazone
Oxiphenbutazonum
Oxybuton
oxyphenbutazone
Oxyphenbutazone (anhydrous)
Oxyphenbutazone (INN)
Oxyphenbutazone (TN)
Oxyphenbutazone [INN]
Oxyphenbutazone anhydrous
Oxyphenbutazone, Tanderil
Oxyphenbutazonum
Oxyphenbutazonum [INN-Latin]
Oxyphenobutazone
Oxyphentamin
Oxyphenyl butazone
Oxyphenylbutazone
p-Hydroxyphenylbutazone
p-Oxyphenylbutazone
Pharmakon1600-01500455
Pirabutina
Piraflogin
Poliflogil
Portoril
Prestwick0_001049
Prestwick1_001049
Prestwick2_001049
Prestwick3_001049
Rapostan
Remazin
Reozon (TN)
Reumox
Reunabutal
Romaxin
Rumapax
SBB057012
SBI-0051471.P003
SCHEMBL25857
SPBio_000286
SPBio_002909
Spectrum_001073
SPECTRUM1500455
Spectrum2_000153
Spectrum3_000535
Spectrum4_001155
Spectrum5_000998
SR-05000001689
SR-05000001689-3
ST50993915
Suganril
Tandacote
Tandalgesic
Tanderal
Tanderil
Telidac
Telidal
Tendearil
Tox21_110414
Tox21_110414_1
Usaf Ge-14
Valioil
Visubutina
VZ36732
WLN: T5VNNV EHJ BR DQ & CR & E4

US Patents and Regulatory Information for TANDEARIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis TANDEARIL oxyphenbutazone TABLET;ORAL 012542-004 Sep 3, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Accenture
McKinsey
Merck
Medtronic
Argus Health
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.